Table 3 Details of infertility screening and diagnostic services in public facilities and private clinics, and overall (n = 38)
|  | Public facilities (n = 20; 53%) | Private clinics (n = 18; 47%) | TOTAL (n = 38; 100%) |
|---|---|---|---|
No screening and diagnostic services | 7 (35%) | 6 (33%) | 13 (34%) |
Screening and/or diagnostic servicesa | 13 (65%) | 12 (67%) | 25 (66%) |
Screening/diagnostic (general) | |||
 Fertility history-taking | 12 (60%) | 12 (67%) | 24 (63%) |
 Physical examination (female) | 12 (60%) | 11 (61%) | 23 (61%) |
 Physical examination (male) | 11 (55%) | 11 (61%) | 22 (58%) |
Screening (female) | |||
 STIs | 12 (60%) | 12 (67%) | 24 (63%) |
 HIV | 12 (60%) | 10 (56%) | 22 (58%) |
 TB | 12 (60%) | 6 (33%) | 18 (47%) |
 Visual inspection w/ acetic acid | 7 (35%) | 5 (28%) | 12 (32%) |
 Smear test | 5 (25%) | 5 (28%) | 10 (26%) |
Screening (male) | |||
 STIs | 11 (55%) | 11 (61%) | 22 (58%) |
 HIV | 12 (60%) | 9 (50%) | 21 (55%) |
 TB | 11 (55%) | 6 (33%) | 17 (45%) |
Diagnostic testing (female) | |||
 Ultrasound (pelvic) | 8 (40%) | 10 (56%) | 18 (47%) |
 Hormonal profile | 0 (0%) | 8 (44%) | 8 (21%) |
 Hysterosalpingogram (HSG) | 1 (5%) | 7 (39%) | 8 (21%) |
 Sonohysterosalpingogram (SHG) | 1 (5%) | 3 (17%) | 4 (11%) |
Diagnostic testing (male) | |||
 Semen analysis | 7 (35%) | 9 (50%) | 16 (42%) |